Several studies on innate immune cells have demonstrated that the myeloid-derived NLRP3 inflammasome complex may contribute to promote inflammatory cytokine production and insulin resistance through reduction of insulin signaling. The gene discussed is NLRP3; the disease is Insulin resistance.